SCHEMBL21150667

SCHEMBL21150667

CCCC(C)N1CCC(C)C1

nearest known ligand 0.39

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 4/20 0.39
OPRM1 P35372 1/20 0.32
OPRL1 P41146 1/20 0.32
MEN1 O00255 1/20 0.32
POLB P06746 1/20 0.32
MAPT P10636 1/20 0.32
KMT2A Q03164 1/20 0.32
UBE2M P61081 7/20 0.32
DCUN1D1 Q96GG9 7/20 0.32
DPP4 P27487 1/20 0.31
DPP8 Q6V1X1 1/20 0.31
DPP7 Q9UHL4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25447572 0.89 SIGMAR1 (0.46) SIGMAR1OPRM1OPRL1MEN1KMT2A
SCHEMBL14197719 0.88 SIGMAR1 (0.37) SIGMAR1OPRM1OPRL1MEN1POLB
SCHEMBL19121468 0.85 SIGMAR1 (0.36) SIGMAR1MEN1KMT2ADPP4DPP8
SCHEMBL15018440 0.83 SIGMAR1 (0.39) SIGMAR1MEN1KMT2A
SCHEMBL15092771 0.83 SIGMAR1 (0.39) SIGMAR1MEN1KMT2A
SCHEMBL15092622 0.83 SIGMAR1 (0.39) SIGMAR1MEN1KMT2A
SCHEMBL15096953 0.83 SIGMAR1 (0.39) SIGMAR1MEN1KMT2A
SCHEMBL19121606 0.83 OPRL1 (0.41) SIGMAR1OPRM1OPRL1
SCHEMBL15019478 0.83 SIGMAR1 (0.39) SIGMAR1MEN1KMT2A
SCHEMBL18256142 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3458105-B1 POLYNUCLEOTIDES ENCODING GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE FOR THE TREATMENT OF GALACTOSEMIA TYPE 1 MODERNATX INC (US) 2024-01-17 EP disclosed
EP-3896164-A1 POLYNUCLEOTIDES ENCODING ALPHA-GALACTOSIDASE A FOR THE TREATMENT OF FABRY DISEASE ModernaTX, Inc. (US) 2021-10-20 EP disclosed
WO-2019136442-A1 CD16A BINDING AGENTS AND USES THEREOF KLEO PHARMACEUTICALS, INC. (US) 2019-07-11 WO disclosed